A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2018 Apr 12

PMID 29636706

Citations 20

Authors

Renata Rizzo

Alessandra Pellico

Paola Rosaria Silvestri

Flavia Chiarotti

Francesco Cardona

Affiliations

Soon will be listed here.

Abstract

Context: The existing literature on the treatment of pediatric chronic tic disorder (CTD) and Tourette syndrome (TS) indicates that both behavioral therapy (BT) and pharmacotherapy (PT) are effective for reducing symptoms.

Objective: To evaluate the efficacy of BT compared to psychoeducation (PE) or PT for reducing tics and co-occurring symptoms and for improving quality of life (QoL) in a sample of youths with CTD and TS.

Design: A 10 weeks, 2 sites (Catania, Rome) randomized controlled trial. Participants were randomized to receive one of the following treatments: BT, PE, or PT.

Participants: 110 outpatients aged between 8 and 17 years affected by CTD or TS.

Results: Patients in the BT and PT groups showed a significant reduction in the severity of tic symptoms, while the PE group did not show any improvement. PT was more effective for reducing obsessive compulsive symptoms than BT, while PE group did not show any improvement. Both BT and PT groups showed an improvement in most QoL domains, whereas no differences were found in the PE group.

Conclusions: BT is as effective as pharmacological therapy in the treatment of tic disorders in children and adolescents, thus offering an alternative to medications for CTD and TS.

Citing Articles

Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities.

Berzosa-Gonzalez I, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Pagonabarraga J Brain Sci. 2025; 14(12.

PMID: 39766430 PMC: 11726857. DOI: 10.3390/brainsci14121231.

Efficacy of Clonidine Adhesive Patch for Patients With Tourette Syndrome: A Randomized, Double-blind, Placebo-Controlled, Multicenter Clinical Trial.

Zhao Z, Qian Y, Du Y, Chen H, He J, Chen Y Clin Neuropharmacol. 2024; 47(5):150-156.

PMID: 39258554 PMC: 11446511. DOI: 10.1097/WNF.0000000000000605.

Deep brain stimulation for Tourette's syndrome.

Wang S, Zhang Y, Wang M, Meng F, Liu Y, Zhang J Cochrane Database Syst Rev. 2024; 8:CD015924.

PMID: 39136257 PMC: 11320656. DOI: 10.1002/14651858.CD015924.

Exploring protocol development: Implementing systematic contextual memory to enhance real-time fMRI neurofeedback.

Fagerland S, Berntsen H, Fredriksen M, Endestad T, Skouras S, Rootwelt-Revheim M J Electr Bioimpedance. 2024; 15(1):41-62.

PMID: 38827812 PMC: 11141335. DOI: 10.2478/joeb-2024-0006.

Online remote behavioural intervention for tics in 9- to 17-year-olds: the ORBIT RCT with embedded process and economic evaluation.

Hollis C, Hall C, Khan K, Le Novere M, Marston L, Jones R Health Technol Assess. 2023; 27(18):1-120.

PMID: 37924247 PMC: 10641713. DOI: 10.3310/CPMS3211.

References

Ganos C, Garrido A, Navalpotro-Gomez I, Ricciardi L, Martino D, Edwards M . Premonitory urge to tic in Tourette's is associated with interoceptive awareness. Mov Disord. 2015; 30(9):1198-202. DOI: 10.1002/mds.26228. View

Gulisano M, Cali P, Palermo F, Robertson M, Rizzo R . Premonitory Urges in Patients with Gilles de la Tourette Syndrome: An Italian Translation and a 7-Year Follow-up. J Child Adolesc Psychopharmacol. 2015; 25(10):810-6. DOI: 10.1089/cap.2014.0154. View

Wilhelm S, Deckersbach T, Coffey B, Bohne A, Peterson A, Baer L . Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry. 2003; 160(6):1175-7. DOI: 10.1176/appi.ajp.160.6.1175. View

Scahill L, Leckman J, Schultz R, Katsovich L, Peterson B . A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003; 60(7):1130-5. DOI: 10.1212/01.wnl.0000055434.39968.67. View

Verdellen C, van de Griendt J, Hartmann A, Murphy T . European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011; 20(4):197-207. DOI: 10.1007/s00787-011-0167-3. View

Piacentini J, Chang S . Behavioral treatments for tic suppression: habit reversal training. Adv Neurol. 2006; 99:227-33. View

McGuire J, Piacentini J, Scahill L, Woods D, Villarreal R, Wilhelm S . Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy. Behav Res Ther. 2015; 70:56-63. PMC: 4449823. DOI: 10.1016/j.brat.2015.05.006. View

Bloch M, Leckman J . Clinical course of Tourette syndrome. J Psychosom Res. 2009; 67(6):497-501. PMC: 3974606. DOI: 10.1016/j.jpsychores.2009.09.002. View

Wilhelm S, Peterson A, Piacentini J, Woods D, Deckersbach T, Sukhodolsky D . Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012; 69(8):795-803. PMC: 3772729. DOI: 10.1001/archgenpsychiatry.2011.1528. View

10.

Woods D, Piacentini J, Scahill L, Peterson A, Wilhelm S, Chang S . Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning. J Child Neurol. 2011; 26(7):858-65. PMC: 4007273. DOI: 10.1177/0883073810397046. View

11.

Steeves T, McKinlay B, Gorman D, Billinghurst L, Day L, Carroll A . Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012; 57(3):144-51. DOI: 10.1177/070674371205700303. View

12.

Piacentini J, Woods D, Scahill L, Wilhelm S, Peterson A, Chang S . Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010; 303(19):1929-37. PMC: 2993317. DOI: 10.1001/jama.2010.607. View

13.

Roessner V, Plessen K, Rothenberger A, Ludolph A, Rizzo R, Skov L . European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011; 20(4):173-96. PMC: 3065650. DOI: 10.1007/s00787-011-0163-7. View

14.

OConnor K, Brault M, Robillard S, Loiselle J, Borgeat F, Stip E . Evaluation of a cognitive-behavioural program for the management of chronic tic and habit disorders. Behav Res Ther. 2001; 39(6):667-81. DOI: 10.1016/s0005-7967(00)00048-6. View

15.

Murphy T, Lewin A, Storch E, Stock S . Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013; 52(12):1341-59. DOI: 10.1016/j.jaac.2013.09.015. View

16.

Verdellen C, Keijsers G, Cath D, Hoogduin C . Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther. 2004; 42(5):501-11. DOI: 10.1016/S0005-7967(03)00154-2. View

17.

Deckersbach T, Rauch S, Buhlmann U, Wilhelm S . Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behav Res Ther. 2005; 44(8):1079-90. DOI: 10.1016/j.brat.2005.08.007. View

18.

van de Griendt J, Verdellen C, van Dijk M, Verbraak M . Behavioural treatment of tics: habit reversal and exposure with response prevention. Neurosci Biobehav Rev. 2012; 37(6):1172-7. DOI: 10.1016/j.neubiorev.2012.10.007. View

19.

Eddy C, Rizzo R, Gulisano M, Agodi A, Barchitta M, Cali P . Quality of life in young people with Tourette syndrome: a controlled study. J Neurol. 2010; 258(2):291-301. DOI: 10.1007/s00415-010-5754-6. View

20.

Yates R, Edwards K, King J, Luzon O, Evangeli M, Stark D . Habit reversal training and educational group treatments for children with tourette syndrome: A preliminary randomised controlled trial. Behav Res Ther. 2016; 80:43-50. DOI: 10.1016/j.brat.2016.03.003. View